ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation
Clinical guideline published by European Research Initiative on CLL (ERIC) on
The European Research Initiative on CLL (ERIC) is a non-profit organization established in 2001, focused on enhancing outcomes for patients with Chronic Lymphocytic Leukemia (CLL). It collaborates with the European Leukemia Net and the European Hematology Association, welcoming professionals in the field.